Inhibikase Therapeutics Balance Sheet (2020-2026) | IKT

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
46.84M44.85M40.75M36.61M32.21M5.78M7.19M3.96M1.91M14.86M9.17M2.35M3.09M0.91M56.49M73.44M77.74M38.27M139.22M49.57M
Short-term Investments (Quarter)
20.75M15.86M21.76M19.03M1.97M4.09M7.40M4.85M2.33M41.05M19.74M9.92M39.05M39.54M120.80M
Cash & Current Investments (Quarter)
46.84M44.85M40.75M36.61M32.21M26.53M23.05M25.72M20.94M16.83M13.25M9.75M7.94M3.24M97.54M93.18M87.67M77.32M178.76M170.37M
Receivables - Net (Quarter)
0.11M0.05M0.01M0.01M0.04M0.06M0.08M
Receivables - Other (Quarter)
0.59M0.22M
Receivables (Quarter)
0.11M0.05M0.01M0.01M0.04M0.06M0.08M
Prepaid Assets (Quarter)
0.96M0.26M0.11M1.17M0.81M0.93M1.12M0.92M0.43M0.35M0.74M0.85M0.31M0.11M0.83M0.05M0.68M0.62M1.00M0.51M
Current Assets (Quarter)
42.47M33.95M27.99M24.37M27.63M21.98M17.55M14.21M10.81M8.60M4.19M98.45M94.16M88.79M78.54M180.11M172.18M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.04M0.24M0.24M0.23M0.09M0.08M0.07M0.07M0.06M0.05M0.05M0.05M0.02M
Other Non-Current Assets (Quarter)
1.00M1.00M1.00M
Non-Current Assets (Quarter)
0.04M0.59M0.57M0.53M0.36M0.33M0.30M0.26M0.22M0.19M0.15M0.12M0.06M1.06M1.10M1.16M
Assets (Quarter)
49.22M45.87M42.47M38.39M33.99M28.58M24.94M28.16M22.35M17.88M14.51M11.07M8.83M4.38M98.60M94.28M88.85M79.59M181.20M173.33M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.77M0.55M1.09M0.81M0.86M0.78M1.15M0.96M19.03M1.97M0.65M1.29M3.38M2.53M0.94M1.69M2.70M0.62M1.16M1.59M
Notes Payables (Quarter)
0.25M0.25M0.25M
Payables (Quarter)
2.02M0.80M1.34M0.81M0.86M0.78M1.15M0.96M19.03M1.97M0.65M1.29M3.38M2.53M0.94M1.69M2.70M0.62M1.16M1.59M
Accumulated Expenses (Quarter)
0.10M1.48M2.08M3.57M3.63M0.42M0.46M0.85M0.98M0.65M2.26M2.09M2.03M2.16M2.68M2.05M0.81M2.11M0.58M4.12M
Other Accumulated Expenses (Quarter)
0.01M0.01M0.01M0.02M0.01M0.03M0.01M100.000.00M100.000.10M0.03M0.01M0.01M0.08M0.13M0.07M0.12M0.21M0.11M
Short term Debt (Quarter)
0.14M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.11M0.07M0.04M
Current Deferred Revenue (Quarter)
0.14M0.02M0.02M
Total Current Liabilities (Quarter)
1.91M2.71M4.05M3.21M3.70M2.66M2.73M2.74M3.44M4.23M3.70M4.91M3.73M8.55M8.80M6.70M8.30M5.71M
Non-Current Liabilities
Capital Leases (Quarter)
0.23M0.21M0.18M0.15M0.12M0.09M0.06M
Non-Current Debt (Quarter)
0.25M
Other Non-Current Liabilities (Quarter)
0.40M
Total Non-Current Liabilities (Quarter)
5.31M
Total Liabilities (Quarter)
2.16M2.71M4.05M4.38M4.49M3.45M3.90M2.84M2.88M2.86M3.53M4.29M3.73M4.91M3.73M8.55M8.80M6.70M8.30M5.71M
Shareholder's Equity
Total Debt (Quarter)
0.25M0.14M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.11M0.07M0.04M
Common Equity (Quarter)
47.05M43.16M38.42M34.01M29.50M25.14M21.04M25.28M19.46M15.02M10.98M6.78M5.10M-0.53M94.87M85.73M80.05M72.90M172.90M167.62M
Shareholder's Equity (Quarter)
47.05M43.16M38.42M34.01M29.50M25.14M21.04M25.28M19.46M15.02M10.98M6.78M5.10M-0.53M94.87M85.73M80.05M72.90M172.90M167.62M
Liabilities and Shareholders Equity (Quarter)
49.22M45.87M42.47M38.39M33.99M28.58M24.94M28.16M22.35M17.88M14.51M11.07M8.83M4.38M98.60M94.28M88.85M79.59M181.20M173.33M
Retained Earnings (Quarter)
-20.30M-24.78M-29.82M-34.46M-39.10M0.03M-47.87M0.17M-58.13M-143.00877.00-0.00M-76.51M0.00M-94.42M-108.10M-118.01M-0.00M0.02M-159.10M